Dabur India’s shares rebounded after the Delhi High Court issued an interim stay on an FSSAI directive, highlighting ongoing legal battles over product claims amid market concerns.
Dabur India shares recovered from an intraday low on Friday after the Delhi High Court granted the company interim relief against a Food Safety and Standards Authority of India directive that had barred sales of several products carrying “100 per cent” claims. The stock was last seen flat to slightly higher at ₹411.75 on the National Stock Exchange after dipping to ₹410.95 earlier in the session.
Justice Amit Mahajan said Dabur had shown a prima facie case because the regulator had acted without first giving the company a hearing, according to a PTI report. The court stayed the order until the next hearing, which is scheduled in about two weeks. Dabur’s lawyers argued that the directive breached principles of natural justice, while government counsel maintained that the company had previously received improvement notices and advisories and that the wording on its food labels could mislead consumers.
The latest case adds to a broader dispute between Dabur and the regulator over product labelling. In March 2025, the company approached the Delhi High Court over an FSSAI move against the use of “100% Fruit Juice” claims on labels and advertisements for reconstituted fruit juice. In that matter, the court issued notice to the regulator, underscoring how closely the dispute over product descriptions is being watched by the market and the industry.
Market watchers said the court order should ease immediate pressure on the stock. Gaurang Shah of Geojit Financial Services told Business Standard that he remains constructive on Dabur because of its long-standing brand equity and broad product range. Still, the shares have been under technical pressure. Hitesh Rathi of Angel One said the stock remains below key moving averages and is sitting near a major support band around ₹410-400, warning that a break lower could deepen the slide. Dabur’s first-quarter revenue had risen 10.6% year on year to ₹3,760 crore, helped by growth in India and overseas markets.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
